Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FP8YD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,017
Award facts
- Contract value 100% obligated
- $30,017.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,017 firm fixed-price delivery order to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Xeomin 200 unit vials, with an ultimate completion date of February 18, 2026. The contract was competitively awarded with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerSourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's federal contract portfolio demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Xeomin, a botulinum toxin product used for therapeutic and cosmetic applications, falls within the company's established expertise in delivering specialty pharmaceuticals to government healthcare systems through firm fixed-price arrangements. The delivery order structure allows DLA to efficiently procure specific medical commodities under the established IDC framework, ensuring timely supply of needed products to support military treatment facilities and related federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FP8YD?
SPE2DR26FP8YD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FP8YD worth?
The government has obligated $30,017 on SPE2DR26FP8YD.
Is contract SPE2DR26FP8YD an order under another contract?
Yes. SPE2DR26FP8YD is a delivery order under SPE2DR25D3005, an indefinite delivery contract.
Was contract SPE2DR26FP8YD competed?
The extent of competition for SPE2DR26FP8YD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award